Andrija Stajduhar was an HBHL Visiting Fellow in 2017 in the neuroinformatics lab of Dr. Alan Evans at the Montreal Neurological Institute听(MNI). He has since returned to his home country, Croatia, where he is a Research Assistant at the
How did you benefit from your HBHL fellowship?
Ghrelin promotes conditioning to food-related odours
The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist. One factor in this hunger response is a hormone found in the stomach that makes us more vulnerable to tasty food smells, encouraging overeating and obesity. New research on the hormone ghrelin was published on Dec. 4, 2018, led by Dr. Alain Dagher鈥檚 lab at the Montreal Neurological Institute and Hospital of 平特五不中.
Congratulations to Dr Louise Pilote, Dr Natalie Dayan, et al. from Anna F. Dominiczak, MD, Editor-in-Chief, Hypertension for an outstanding contribution to Hypertension.
The first round of the 平特五不中-Western Collaboration Grant awards was announced today, showcasing the unique research partnership between Western University鈥檚 and 平特五不中鈥檚 Healthy Brains for Healthy Lives (HBHL) initiative. In the inaugural round, seven research teams, each co-led by a Western and 平特五不中 faculty member, have been awarded funding for their transformational research projects that aim to radically transform our understanding of the brain.
Brain cancer begins in stem cells, targeting them may prevent tumour growth
Researchers at the Montreal Neurological Institute and Hospital (The Neuro) have found an exciting new way of treating brain cancer.
Late stage brain cancer cells are heterogeneous 鈥� they differ down to the molecular level. This makes developing treatments at this stage difficult, because a drug that may be effective against one cell may not be effective against another.
Carriers at higher risk of developing neurodegenerative disease
A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro) has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson鈥檚 disease (PD), dementia with Lewy-Bodies (DLB) and multiple system atrophy (MSA).
Plasticity is enhanced but dysregulated in the aging brain
They say you can鈥檛 teach old dogs new tricks, but new research shows you can teach an old rat new sounds, even if the lesson doesn鈥檛 stick very long.
When it comes to weight gain, the problem may be mostly in our heads, and our genes
Clinicians should consider how the way we think can make us vulnerable to obesity, and how obesity is genetically intertwined with brain structure and mental performance, according to new research.
Technique can be used to better categorize patients with neurological disease, according to their therapeutic needs
Personalized medicine 鈥� delivering therapies specially tailored to a patient鈥檚 unique physiology 鈥� has been a goal of researchers and doctors for a long time. New research provides a way of delivering personalized treatments to patients with neurological disease.
On April 20, 2018, Canadian, Chinese and Cuban neuroscience institutes strengthened an existing partnership with the signing of a memorandum of understanding in Chengdu, China.
Partners in the agreement include The Montreal Neurological Institute and Hospital (The Neuro) of 平特五不中, The Cuban Neuroscience Center, The University of Electronic Sciences and Technology of China, The West China Hospital, and The Tianfu New Area of Chengdu (TFNA).
The Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the 鈥淢ontreal Procedure,鈥� which today is in use throughout the world. The Neuro became a pioneer in studying epilepsy through the use of electroencephalography (EEG) and magnetic resonance imaging (MRI).
Qu茅bec Science magazine鈥檚 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner. This year, a cancer-detection probe was chosen by nearly a third of approximately 4,400 votes cast in the 2017 Discovery of the Year contest.
Congratulations to Assistant Professor Dr. Huy Bui, who has been named a 2017 CIFAR Azrieli Global Scholar!
Collaboration between departmental members Drs. D. Reinhardt and P. Campeau has received new 5-year funding from the Canadian Institutes of Health Research for the grant entitled 鈥淩ole of fibronectin mutations in spondylometaphyseal dysplasia and idiopathic scoliosis鈥� in the amount of $680,850. Congratulations!
听
听
Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research
